Ultrafiltration Membranes: Technologies and the U.S. Market
- The U.S. market for ultrafiltration technologies was worth $882 million in 2009 and will reach $932 million by the end of 2010. By 2015, the market is estimated to be valued at $1.2 billion, a compound annual growth rate (CAGR) of 5.7%.
- Hemodialysis is the largest ultrafiltration application market, with 52% market share in 2010. The market for hemodialyzers will reach $485 million by the end of 2010 and $626 million by 2015, a compound annual growth rate (CAGR) of 5.2%.
- The biotechnology sector is expected to continue growing robustly over the next 5 years. The market for UF products used in biotech research, biopharmaceuticals processing, and compendial water production is worth approximately $80 million in 2010. Growth in the market from 2010 to 2015 is forecast to rise at a compound annual growth rate (CAGR) of 10.2%, for a value of $130 million.
- Examine BCC’s complete catalog of Market Research Reports and place direct orders
- Subscribe to any of BCC’s many industry newsletters
- Read announcements of recently published reports and newly launched newsletters
- Register for BCC’s well-known conferences
- Request additional information on any BCC product
- Take advantage of special offers.
- The total U.S. market value for ultrafiltration membranes was worth $579 million in 2005 and $635 million in 2006. At a compound annual growth rate (CAGR) of 7.4%, this market will reach $908 million by 2011.
- Broken down between bioseparations/medical and municipal/industrial applications, the market remains largely split down the middle throughout the forecast period. Bioseparations will grow slightly to 52% of the total market value throughout the forecast period, while municipal/industrial applications will drop slightly to 47%
- Bioseparation/medical applications have the highest CAGR throughout the forecast period. In 2006 this sector of the market was worth $324 million and will grow to $476 million by 2011, a CAGR of 8.0%.
The market for ultrafiltration will rise at an average annual growth rate (AAGR) of 9.7% from $458 million in 2002 to $727 million in 2007.
Profitable new applications are developing in separations needed for neutraceuticals manufacture, a rapidly growing sector.
The phase-out of reusable dialyzers, increased use of more expensive synthetic membranes and an expanding patient population should continue to grow the dialysis market.
Potable water production potentially is a very large market for UF membranes Municipal wastewater recycling, using UF, is gaining attention for nonpotable reuse in irrigation and groundwater recharge; the notion that treated wastewater can be recycled as potable also is advancing.